Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?

Detalles Bibliográficos
Autores principales: Wojtukiewicz, Marek Z., Pogorzelska, Magda, Politynska, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470645/
https://www.ncbi.nlm.nih.gov/pubmed/36066779
http://dx.doi.org/10.1007/s10555-022-10060-4
_version_ 1784788889124208640
author Wojtukiewicz, Marek Z.
Pogorzelska, Magda
Politynska, Barbara
author_facet Wojtukiewicz, Marek Z.
Pogorzelska, Magda
Politynska, Barbara
author_sort Wojtukiewicz, Marek Z.
collection PubMed
description
format Online
Article
Text
id pubmed-9470645
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-94706452022-09-15 Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end? Wojtukiewicz, Marek Z. Pogorzelska, Magda Politynska, Barbara Cancer Metastasis Rev Commentary Springer US 2022-09-06 2022 /pmc/articles/PMC9470645/ /pubmed/36066779 http://dx.doi.org/10.1007/s10555-022-10060-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Commentary
Wojtukiewicz, Marek Z.
Pogorzelska, Magda
Politynska, Barbara
Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?
title Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?
title_full Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?
title_fullStr Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?
title_full_unstemmed Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?
title_short Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?
title_sort immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470645/
https://www.ncbi.nlm.nih.gov/pubmed/36066779
http://dx.doi.org/10.1007/s10555-022-10060-4
work_keys_str_mv AT wojtukiewiczmarekz immunotherapyfortriplenegativebreastcancertheendofthebeginningorthebeginningoftheend
AT pogorzelskamagda immunotherapyfortriplenegativebreastcancertheendofthebeginningorthebeginningoftheend
AT politynskabarbara immunotherapyfortriplenegativebreastcancertheendofthebeginningorthebeginningoftheend

Ejemplares similares